Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | Moreland Mary K | EXECUTIVE VICE PRESIDENT | Mar 01, 2024 | Sale | $118.50 | 676 | 80,106 | 91,260 | Mar 04, 2024, 07:09 PM | |
ABT | ABBOTT LABORATORIES | Moreland Mary K | EXECUTIVE VICE PRESIDENT | Feb 29, 2024 | Option Exercise | $120.05 | 5,862 | 703,733 | 91,936 | Mar 04, 2024, 07:09 PM | |
ABT | ABBOTT LABORATORIES | Moreland Mary K | EXECUTIVE VICE PRESIDENT | Feb 28, 2023 | Option Exercise | $99.77 | 5,926 | 591,237 | 87,941 | Mar 02, 2023, 07:45 PM | |
ABT | ABBOTT LABORATORIES | Moreland Mary K | EXECUTIVE VICE PRESIDENT | Mar 01, 2023 | Sale | $100.77 | 717 | 72,252 | 87,224 | Mar 02, 2023, 07:45 PM | |
ABT | ABBOTT LABORATORIES | Moreland Mary K | EXECUTIVE VICE PRESIDENT | Aug 01, 2022 | Option Exercise | $108.84 | 1,245 | 135,506 | 81,608 | Aug 03, 2022, 12:27 PM | |
ABT | ABBOTT LABORATORIES | Moreland Mary K | EXECUTIVE VICE PRESIDENT | Feb 28, 2022 | Option Exercise | $122.41 | 4,112 | 503,350 | 82,853 | Mar 02, 2022, 07:52 PM | |
ABT | ABBOTT LABORATORIES | Moreland Mary K | EXECUTIVE VICE PRESIDENT | Feb 22, 2022 | Option Exercise | $116.79 | 793 | 92,614 | 87,365 | Feb 23, 2022, 08:23 PM | |
ABT | ABBOTT LABORATORIES | Moreland Mary K | EXECUTIVE VICE PRESIDENT | Feb 22, 2021 | Sale | $119.31 | 400 | 47,723 | 86,965 | Feb 23, 2022, 08:23 PM | |
ABT | ABBOTT LABORATORIES | Moreland Mary K | EXECUTIVE VICE PRESIDENT | Aug 01, 2021 | Option Exercise | $120.98 | 1,245 | 150,620 | 72,345 | Aug 03, 2021, 05:40 PM | |
ABT | ABBOTT LABORATORIES | Moreland Mary K | EXECUTIVE VICE PRESIDENT | Feb 26, 2021 | Option Exercise | $121.58 | 2,116 | 257,263 | 73,590 | Mar 02, 2021, 07:44 PM | |
ABT | ABBOTT LABORATORIES | Moreland Mary K | EXECUTIVE VICE PRESIDENT | Feb 22, 2021 | Sale | $122.63 | 1,180 | 144,705 | 76,106 | Feb 23, 2021, 07:05 PM | |
ABT | ABBOTT LABORATORIES | Moreland Mary K | EXECUTIVE VICE PRESIDENT | Feb 16, 2021 | Sale | $128.32 | 1,514 | 194,272 | 63,878 | Feb 18, 2021, 05:57 PM | |
ABT | ABBOTT LABORATORIES | Moreland Mary K | Executive Vice President | Aug 01, 2020 | Option Exercise | $100.64 | 1,244 | 125,196 | 64,887 | Aug 04, 2020, 05:15 PM | |
ABT | ABBOTT LABORATORIES | Moreland Mary K | Executive Vice President | Feb 22, 2020 | Option Exercise | $87.45 | 780 | 68,211 | 66,531 | Feb 25, 2020, 05:29 PM | |
ABT | ABBOTT LABORATORIES | Moreland Mary K | Executive Vice President | Feb 25, 2020 | Sale | $84.93 | 400 | 33,972 | 66,131 | Feb 25, 2020, 05:29 PM | |
ABT | ABBOTT LABORATORIES | Moreland Mary K | Executive Vice President | Feb 17, 2020 | Option Exercise | $89.66 | 1,004 | 90,019 | 54,004 | Feb 19, 2020, 05:53 PM | |
ABT | ABBOTT LABORATORIES | Moreland Mary K | Executive Vice President | Feb 19, 2020 | Sale | $88.97 | 1,019 | 90,660 | 52,985 | Feb 19, 2020, 05:53 PM | |
ABT | ABBOTT LABORATORIES | Moreland Mary K | Executive Vice President | Feb 16, 2020 | Option Exercise | $89.66 | 1,020 | 91,453 | 55,008 | Feb 19, 2020, 05:53 PM |